<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> is a progressive cerebrovascular occlusive disease affecting primarily children </plain></SENT>
<SENT sid="1" pm="."><plain>The etiology remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>We examined the chemotactic and proliferative activities of inflammatory cell products from arterial smooth muscle cells (SMCs) derived from <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> patients and compared them with those from control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We used 12 SMC strains from <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> patients and eight from control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>SMC migration was examined in a micro chemotaxis chamber </plain></SENT>
<SENT sid="5" pm="."><plain>DNA synthesis was measured by an immunoperoxidase technique </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Platelet-derived growth factor (PDGF)-BB markedly stimulated cell migration and DNA synthesis in control SMCs </plain></SENT>
<SENT sid="7" pm="."><plain>PDGF-AA stimulated only DNA synthesis in control SMCs </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs, PDGF-AA and PDGF-BB stimulated cell migration but not DNA synthesis </plain></SENT>
<SENT sid="9" pm="."><plain>Basic fibroblast growth factor had little migratory activity but stimulated DNA synthesis in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs and control SMCs </plain></SENT>
<SENT sid="10" pm="."><plain>Conversely, hepatocyte growth factor stimulated cell migration but not DNA synthesis in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs and control SMCs </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, interleukin-1 beta (IL-1 beta) significantly stimulated the migration and DNA synthesis of control SMCs, while it inhibited <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMC migration </plain></SENT>
<SENT sid="12" pm="."><plain>The levels of IL-1 beta-induced nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> production did not differ between <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs and control SMCs, suggesting that IL-1 beta inhibits the migration of <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs through a nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>-independent pathway </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: The differences in responses to PDGF and IL-1 in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya</z:e> SMCs are involved in the mechanism by which intimal thickening develops in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> </plain></SENT>
</text></document>